Condensed Consolidated Statements of Equity - USD ($) $ in Thousands		Total		Total Stockholders’ Equity (Deficit)	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Noncontrolling Interests in Subsidiaries
Stockholders' equity, beginning of period (in shares) at Dec. 29, 2019					168,121,000
Stockholders' equity, beginning of period at Dec. 29, 2019		$ 21,499		$ 10,163	$ 168	$ 2,661,819	$ (192,633)	$ (9,512)	$ (2,449,679)	$ 11,336
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(2,138)		(1,431)					(1,431)	(707)
Other comprehensive income (loss)		723		723				723
Issuance of restricted stock to employees, net of cancellations (in shares)					2,452,000
Issuance of restricted stock to employees, net of cancellations		3		3	$ 3
Stock-based compensation expense		6,885		6,885		6,885
Purchases of treasury stock (in shares)					(818,000)
Purchases of treasury stock		(6,911)		(6,911)	$ (1)		(6,910)
Stockholders' equity, end of period (in shares) at Mar. 29, 2020					169,755,000
Stockholders' equity, end of period at Mar. 29, 2020		20,061		9,432	$ 170	2,668,704	(199,543)	(8,789)	(2,451,110)	10,629
Stockholders' equity, beginning of period (in shares) at Dec. 29, 2019					168,121,000
Stockholders' equity, beginning of period at Dec. 29, 2019		21,499		10,163	$ 168	2,661,819	(192,633)	(9,512)	(2,449,679)	11,336
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)		175
Stockholders' equity, end of period (in shares) at Sep. 27, 2020					170,139,000
Stockholders' equity, end of period at Sep. 27, 2020		(7,066)		(10,299)	$ 170	2,679,960	(201,090)	8,070	(2,497,409)	3,233
Stockholders' equity, beginning of period (in shares) at Mar. 29, 2020					169,755,000
Stockholders' equity, beginning of period at Mar. 29, 2020		20,061		9,432	$ 170	2,668,704	(199,543)	(8,789)	(2,451,110)	10,629
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		18,398		19,378					19,378	(980)
Other comprehensive income (loss)		(1,576)		(1,576)				(1,576)
Issuance of restricted stock to employees, net of cancellations (in shares)					533,000
Stock-based compensation expense		5,675		5,675		5,675
Purchases of treasury stock (in shares)					(229,000)
Purchases of treasury stock		(1,253)		(1,253)			(1,253)
Stockholders' equity, end of period (in shares) at Jun. 28, 2020					170,059,000
Stockholders' equity, end of period at Jun. 28, 2020		41,305		31,656	$ 170	2,674,379	(200,796)	(10,365)	(2,431,732)	9,649
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		45,114		44,626					44,626	488
Other comprehensive income (loss)		1,028		1,028				1,028
Distributions to non-controlling interest		(302)								(302)
Issuance of restricted stock to employees, net of cancellations (in shares)					111,000
Stock-based compensation expense		5,581		5,581		5,581
Purchases of treasury stock (in shares)					(31,000)
Purchases of treasury stock		(294)		(294)			(294)
Issuance of Maxeon Solar green convertible notes		53,040		53,040		53,040
Contributions to non-controlling interest		22								22
Impact of Maxeon Solar Spin-Off		(152,560)		(145,936)		(53,040)		17,407	(110,303)	(6,624)
Stockholders' equity, end of period (in shares) at Sep. 27, 2020					170,139,000
Stockholders' equity, end of period at Sep. 27, 2020		$ (7,066)		(10,299)	$ 170	2,679,960	(201,090)	8,070	(2,497,409)	3,233
Stockholders' equity, beginning of period (in shares) at Jan. 03, 2021		170,428,000			170,428,000
Stockholders' equity, beginning of period at Jan. 03, 2021		$ 406,486		404,167	$ 170	2,685,920	(205,476)	8,799	(2,085,246)	2,319
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(49,498)		(48,385)					(48,385)	(1,113)
Other comprehensive income (loss)		98		98				98
Issuance of restricted stock to employees, net of cancellations (in shares)					1,908,000
Issuance of restricted stock to employees, net of cancellations		2		2	$ 2
Stock-based compensation expense	[1]	5,437		5,437		5,437
Bond/debentures conversion (in shares)					4,000
Bond/debentures conversion		155		155		155
Purchases of treasury stock (in shares)					(76,000)
Purchases of treasury stock		(2,120)		(2,120)			(2,120)
Other adjustments		303		303		(89)			392
Stockholders' equity, end of period (in shares) at Apr. 04, 2021					172,264,000
Stockholders' equity, end of period at Apr. 04, 2021		$ 360,863		359,657	$ 172	2,691,423	(207,596)	8,897	(2,133,239)	1,206
Stockholders' equity, beginning of period (in shares) at Jan. 03, 2021		170,428,000			170,428,000
Stockholders' equity, beginning of period at Jan. 03, 2021		$ 406,486		404,167	$ 170	2,685,920	(205,476)	8,799	(2,085,246)	2,319
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)		$ 576
Stockholders' equity, end of period (in shares) at Oct. 03, 2021		172,915,000			172,915,000
Stockholders' equity, end of period at Oct. 03, 2021		$ 367,005		366,168	$ 172	2,711,769	(212,740)	9,375	(2,142,408)	837
Stockholders' equity, beginning of period (in shares) at Apr. 04, 2021					172,264,000
Stockholders' equity, beginning of period at Apr. 04, 2021		360,863		359,657	$ 172	2,691,423	(207,596)	8,897	(2,133,239)	1,206
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		74,769		75,207					75,207	(438)
Other comprehensive income (loss)		492		492				492
Issuance of restricted stock to employees, net of cancellations (in shares)					664,000
Issuance of common stock to executive (in shares)	[2]				101,000
Issuance of common stock to executive	[2]	2,999		2,999		2,999
Stock-based compensation expense	[1]	9,225		9,225		9,225
Purchases of treasury stock (in shares)					(187,000)
Purchases of treasury stock		(4,310)		(4,310)			(4,310)
Other adjustments		(25)		(25)			(25)
Stockholders' equity, end of period (in shares) at Jul. 04, 2021					172,842,000
Stockholders' equity, end of period at Jul. 04, 2021		444,013		443,245	$ 172	2,703,647	(211,931)	9,389	(2,058,032)	768
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(84,307)		(84,376)					(84,376)	69
Other comprehensive income (loss)		(14)		(14)				(14)
Issuance of restricted stock to employees, net of cancellations (in shares)					107,000
Issuance of restricted stock to employees, net of cancellations		0
Stock-based compensation expense		4,725	[1]	4,725		4,725
Purchases of treasury stock (in shares)					(34,000)
Purchases of treasury stock		(809)		(809)			(809)
Income taxes3	[3]	$ 3,397		3,397		3,397
Stockholders' equity, end of period (in shares) at Oct. 03, 2021		172,915,000			172,915,000
Stockholders' equity, end of period at Oct. 03, 2021		$ 367,005		$ 366,168	$ 172	$ 2,711,769	$ (212,740)	$ 9,375	$ (2,142,408)	$ 837

[1] Stock-based compensation expense includes a recharge to Maxeon Solar of $0.4 million for the nine months ended October 3, 2021, under the collaboration agreement (see Note 11. Related-Party Transactions). There was no recharge to Maxeon Solar in the three months ended October 3, 2021.

[2] Refer to Note 11. Related-Party Transactions for details.

[3] Relates to a reduction of income tax liability resulting from utilization of carryover R&D credits on book to tax difference on interest on convertible debt.